These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 2154606)

  • 1. Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1.
    Flemington E; Speck SH
    J Virol; 1990 Mar; 64(3):1227-32. PubMed ID: 2154606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1.
    Flemington E; Speck SH
    J Virol; 1990 Mar; 64(3):1217-26. PubMed ID: 2154605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the ZI domains in the Epstein-Barr virus BZLF1 gene promoter: role in phorbol ester induction.
    Borras AM; Strominger JL; Speck SH
    J Virol; 1996 Jun; 70(6):3894-901. PubMed ID: 8648726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a negative cis element within the ZII domain of the Epstein-Barr virus lytic switch BZLF1 gene promoter.
    Liu P; Liu S; Speck SH
    J Virol; 1998 Oct; 72(10):8230-9. PubMed ID: 9733866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
    Gradoville L; Kwa D; El-Guindy A; Miller G
    J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-binding-defective mutants of the Epstein-Barr virus lytic switch activator Zta transactivate with altered specificities.
    Flemington EK; Lytle JP; Cayrol C; Borras AM; Speck SH
    Mol Cell Biol; 1994 May; 14(5):3041-52. PubMed ID: 8164660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.
    Fahmi H; Cochet C; Hmama Z; Opolon P; Joab I
    J Virol; 2000 Jul; 74(13):5810-8. PubMed ID: 10846060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells.
    Hergenhahn M; Soto U; Weninger A; Polack A; Hsu CH; Cheng AL; Rösl F
    Mol Carcinog; 2002 Mar; 33(3):137-45. PubMed ID: 11870879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of the ubiquitous cellular transcription factors Sp1 and Sp3 to the ZI domains in the Epstein-Barr virus lytic switch BZLF1 gene promoter.
    Liu S; Borras AM; Liu P; Suske G; Speck SH
    Virology; 1997 Feb; 228(1):11-8. PubMed ID: 9024805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the 12-O-tetradecanoylphorbol-13-acetate-responsive enhancer of the MS gene of the Epstein-Barr virus.
    Liu Q; Summers WC
    J Biol Chem; 1992 Jun; 267(17):12049-54. PubMed ID: 1318308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of ZIIBC, a complex formed by cellular factors and the ZII site of the Epstein-Barr virus BZLF1 promoter.
    Ruf IK; Rawlins DR
    J Virol; 1995 Dec; 69(12):7648-57. PubMed ID: 7494273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras.
    Kolman JL; Taylor N; Gradoville L; Countryman J; Miller G
    J Virol; 1996 Mar; 70(3):1493-504. PubMed ID: 8627667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions.
    Lieberman PM; Hardwick JM; Sample J; Hayward GS; Hayward SD
    J Virol; 1990 Mar; 64(3):1143-55. PubMed ID: 2154599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells.
    Daibata M; Speck SH; Mulder C; Sairenji T
    Virology; 1994 Feb; 198(2):446-54. PubMed ID: 8291228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein-Barr virus BZLF1 promoter.
    Taylor N; Flemington E; Kolman JL; Baumann RP; Speck SH; Miller G
    J Virol; 1991 Aug; 65(8):4033-41. PubMed ID: 1649314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the Epstein-Barr virus transcription factor BZLF1 by 12-O-tetradecanoylphorbol-13-acetate-induced phosphorylation.
    Baumann M; Mischak H; Dammeier S; Kolch W; Gires O; Pich D; Zeidler R; Delecluse HJ; Hammerschmidt W
    J Virol; 1998 Oct; 72(10):8105-14. PubMed ID: 9733851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
    Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE
    J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus.
    Yu X; Wang Z; Mertz JE
    PLoS Pathog; 2007 Dec; 3(12):e194. PubMed ID: 18085824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors.
    Countryman JK; Gradoville L; Miller G
    J Virol; 2008 May; 82(10):4706-19. PubMed ID: 18337569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic AMP-responsive element-dependent activation of Epstein-Barr virus zebra promoter by human herpesvirus 6.
    Flamand L; Menezes J
    J Virol; 1996 Mar; 70(3):1784-91. PubMed ID: 8627701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.